RPE65 and Parkinson disease: For example, AAV2-GAD (glutamic acid decarboxylase) is being trialled for advanced Parkinson's disease and AAV2-RPE65 (retinal pigment epithelium-specific 65 kDa protein) is under investigation for severe retinal dystrophy.